domingo, 11 de octubre de 2020

Cutting off H-1B visas will hurt the biopharma industry - STAT

Cutting off H-1B visas will hurt the biopharma industry - STAT

First Opinion

Cutting off H-1B visas will hurt the biopharma industry

By ELIZABETH O'DAY


ADOBE
There aren't enough Americans trained to fill many job openings in the biopharma industry. H-1B visa limitations won't solve that problem.

No hay comentarios: